VBCR - October 2017, Vol 6, No 4
Results from a new registry of Manhattan, NY, residents has revealed that Asian/Pacific Islanders and Hispanics of any race are more likely to be affected by systemic lupus erythematosus (SLE) than people who are white (Izmirly PM, et al. Arthritis Rheumatol. 2017 Sep 10. Epub ahead of print).
In the CRADLE study, Megan E.B. Clowse, MD, Associate Professor of Medicine, Duke University School of Medicine, Durham, NC, and colleagues, evaluated the concentrations of certolizumab pegol in mature breast milk of patients receiving this biologic, and calculated the average daily dose of certolizumab pegol potentially ingested by infants being breastfed.
“Over the years, numerous observational studies have associated patients with RA with the increased risk of osteoporosis fracture involving mainly the hip or vertebral. However, most clinical studies performed are either limited in sample size, restricted to certain subpopulation, or are fracture-site specific.
Results from a recent study suggest that working in certain occupations may increase a worker’s risk for rheumatoid arthritis (RA), even after adjustment for lifestyle-related factors, including smoking, alcohol use, education level, and obesity (Ilar A, et al. Arthritis Care Res (Hoboken). 2017 Aug 10. Epub ahead of print).
Sustained Disease Remission Increased by Adding Tocilizumab to Glucocorticoid Therapy in Patients with Giant-Cell Arteritis
Adding tocilizumab to tapered glucocorticoid therapy in patients with giant-cell arteritis (GCA) led to higher rates of sustained remission at 52 weeks than placebo plus tapered glucocorticoid therapy, according to the results of the phase 3, randomized, double-blind, 52-week, placebo-controlled GiACTA (GCA Actemra) trial.
- Smartphone Application Improves Self-Management Among Patients with Juvenile Idiopathic Arthritis
- Hospital-Based Rheumatoid Arthritis Infusion Therapy Associated with Substantial Costs
- Patient Support Program Associated with Greater Adherence Among Patients Receiving Adalimumab
- Above-Label Dosing for Patients with Psoriasis Leads to Higher Treatment Costs
The Lupus Research Alliance, a national voluntary health organization, has joined forces with Pfizer and Tata Consultancy Services to launch a new, custom, smartphone application that will allow patients with lupus to report symptoms of their disease via their iPhones.
“The aim of the current study is to investigate the ability of the algorithm to separate clinically healthy but obese subjects, diagnosed from the baseline radiographs, into different KL grade groups based on the predicted level of cartilage degeneration,” Ms Liukkonen and colleagues explained.
Page 1 of 2
Results 1 - 10 of 11
Results 1 - 10 of 11